121 related articles for article (PubMed ID: 31617175)
1. HSV-1 Amplicon Vectors as Genetic Vaccines.
Meier AF; Laimbacher AS
Methods Mol Biol; 2020; 2060():111-130. PubMed ID: 31617175
[TBL] [Abstract][Full Text] [Related]
2. HSV-1 amplicon vectors as genetic vaccines.
Laimbacher AS; Fraefel C
Methods Mol Biol; 2014; 1144():99-115. PubMed ID: 24671679
[TBL] [Abstract][Full Text] [Related]
3. HSV-1 amplicon vectors launch the production of heterologous rotavirus-like particles and induce rotavirus-specific immune responses in mice.
Laimbacher AS; Esteban LE; Castello AA; Abdusetir Cerfoglio JC; Argüelles MH; Glikmann G; D'Antuono A; Mattion N; Berois M; Arbiza J; Hilbe M; Schraner EM; Seyffert M; Dresch C; Epstein AL; Ackermann M; Fraefel C
Mol Ther; 2012 Sep; 20(9):1810-20. PubMed ID: 22713696
[TBL] [Abstract][Full Text] [Related]
4. Transfer of Anti-Rotavirus Antibodies during Pregnancy and in Milk Following Maternal Vaccination with a Herpes Simplex Virus Type-1 Amplicon Vector.
Meier AF; Suter M; Schraner EM; Humbel BM; Tobler K; Ackermann M; Laimbacher AS
Int J Mol Sci; 2017 Feb; 18(2):. PubMed ID: 28212334
[TBL] [Abstract][Full Text] [Related]
5. HSV-1 amplicon vectors that direct the in situ production of foot-and-mouth disease virus antigens in mammalian cells can be used for genetic immunization.
D'Antuono A; Laimbacher AS; La Torre J; Tribulatti V; Romanutti C; Zamorano P; Quattrocchi V; Schraner EM; Ackermann M; Fraefel C; Mattion N
Vaccine; 2010 Oct; 28(46):7363-72. PubMed ID: 20851082
[TBL] [Abstract][Full Text] [Related]
6. Preparation of Herpes Simplex Virus Type 1 (HSV-1)-Based Amplicon Vectors.
Fraefel C; Epstein AL
Methods Mol Biol; 2020; 2060():91-109. PubMed ID: 31617174
[TBL] [Abstract][Full Text] [Related]
7. HSV/AAV hybrid amplicon vectors extend transgene expression in human glioma cells.
Johnston KM; Jacoby D; Pechan PA; Fraefel C; Borghesani P; Schuback D; Dunn RJ; Smith FI; Breakefield XO
Hum Gene Ther; 1997 Feb; 8(3):359-70. PubMed ID: 9048203
[TBL] [Abstract][Full Text] [Related]
8. Polycistronic Herpesvirus Amplicon Vectors for Veterinary Vaccine Development.
Meier AF; Laimbacher AS; Ackermann M
Methods Mol Biol; 2016; 1349():201-24. PubMed ID: 26458838
[TBL] [Abstract][Full Text] [Related]
9. Helper virus-free herpes simplex virus type 1 amplicon vectors for granulocyte-macrophage colony-stimulating factor-enhanced vaccination therapy for experimental glioma.
Herrlinger U; Jacobs A; Quinones A; Woiciechowsky C; Sena-Esteves M; Rainov NG; Fraefel C; Breakefield XO
Hum Gene Ther; 2000 Jul; 11(10):1429-38. PubMed ID: 10910140
[TBL] [Abstract][Full Text] [Related]
10. Construction and packaging of herpes simplex virus/adeno-associated virus (HSV/AAV) Hybrid amplicon vectors.
Saydam O; Glauser DL; Fraefel C
Cold Spring Harb Protoc; 2012 Mar; 2012(3):352-6. PubMed ID: 22383640
[TBL] [Abstract][Full Text] [Related]
11. Expression of human papilloma virus type 16 antigens, specific targeting as well as formation of virus-like particles by HSV-1 amplicon vectors.
Schenck S; Kehm E; Epstein AL; Zentgraf H; Müller M; Knopf CW
Virus Genes; 2008 Oct; 37(2):131-43. PubMed ID: 18548342
[TBL] [Abstract][Full Text] [Related]
12. Herpes simplex virus type-1 amplicon vectors for vaccine generation in acute lymphoblastic leukemia.
Zibert A; Thomassen A; Müller L; Nguyen L; Glouchkova L; Fraefel C; Roskrow M; Meisel R; Dilloo D
Gene Ther; 2005 Dec; 12(23):1707-17. PubMed ID: 16034459
[TBL] [Abstract][Full Text] [Related]
13. Herpes simplex virus type 1/adeno-associated virus hybrid vectors mediate site-specific integration at the adeno-associated virus preintegration site, AAVS1, on human chromosome 19.
Heister T; Heid I; Ackermann M; Fraefel C
J Virol; 2002 Jul; 76(14):7163-73. PubMed ID: 12072516
[TBL] [Abstract][Full Text] [Related]
14. Murine Bone Marrow-Derived Dendritic Cells Transduced by Light-Helper-Dependent Herpes Simplex Virus-1 Amplicon Vector Acquire a Mature Dendritic Cell Phenotype.
Oz-Arslan D; Tsitoura E; Kazazi D; Kouvatsis V; Epstein AL; Mavromara P
Hum Gene Ther Methods; 2015 Jun; 26(3):93-102. PubMed ID: 26046494
[TBL] [Abstract][Full Text] [Related]
15. Recombinant adeno-associated virus type 2 replication and packaging is entirely supported by a herpes simplex virus type 1 amplicon expressing Rep and Cap.
Conway JE; Zolotukhin S; Muzyczka N; Hayward GS; Byrne BJ
J Virol; 1997 Nov; 71(11):8780-9. PubMed ID: 9343238
[TBL] [Abstract][Full Text] [Related]
16. Gene transfer into hepatocytes mediated by helper virus-free HSV/AAV hybrid vectors.
Fraefel C; Jacoby DR; Lage C; Hilderbrand H; Chou JY; Alt FW; Breakefield XO; Majzoub JA
Mol Med; 1997 Dec; 3(12):813-25. PubMed ID: 9440115
[TBL] [Abstract][Full Text] [Related]
17. Generation of high-titer defective HSV-1 vectors.
Lim F; Neve RL
Curr Protoc Neurosci; 2001 May; Chapter 4():Unit 4.13. PubMed ID: 18428477
[TBL] [Abstract][Full Text] [Related]
18. An enhanced packaging system for helper-dependent herpes simplex virus vectors.
Stavropoulos TA; Strathdee CA
J Virol; 1998 Sep; 72(9):7137-43. PubMed ID: 9696807
[TBL] [Abstract][Full Text] [Related]
19. Expression of hepatitis C virus envelope glycoproteins by herpes simplex virus type 1-based amplicon vectors.
Tsitoura E; Lucas M; Revol-Guyot V; Epstein AL; Manservigi R; Mavromara P
J Gen Virol; 2002 Mar; 83(Pt 3):561-566. PubMed ID: 11842251
[TBL] [Abstract][Full Text] [Related]
20. Expression of human immunodeficiency virus type 1 gp120 from herpes simplex virus type 1-derived amplicons results in potent, specific, and durable cellular and humoral immune responses.
Hocknell PK; Wiley RD; Wang X; Evans TG; Bowers WJ; Hanke T; Federoff HJ; Dewhurst S
J Virol; 2002 Jun; 76(11):5565-80. PubMed ID: 11991985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]